Lu Xia

[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].

Jun Chen, Danping Liu, Li Liu et al. · PubMed · 2020 · 706 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19

Jun Chen, Lu Xia, Li Liu et al. · Open Forum Infectious Diseases · 2020 · 127 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Proliferation and osteogenic differentiation of human periodontal ligament cells on akermanite and β-TCP bioceramics

Lu Xia, Zhiying Zhang, Lei Chen et al. · European Cells and Materials · 2011 · 101 citations · Full text

Dentistry, Oral Biology, Periodontics +17

Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study

Lu Xia, Yujing Shi, Jie Su et al. · Phytomedicine · 2020 · 92 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17

Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis: an open-label, randomized, two-centre phase 2a clinical trial

F. Li, Miao Xu, Cheng Xue Qin et al. · Clinical Microbiology and Infection · 2016 · 50 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17